BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23598488)

  • 1. Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities.
    Birkett AJ; Moorthy VS; Loucq C; Chitnis CE; Kaslow DC
    Vaccine; 2013 Apr; 31 Suppl 2():B233-43. PubMed ID: 23598488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].
    Cohen J; Benns S; Vekemans J; Leach A
    Ann Pharm Fr; 2010 Nov; 68(6):370-9. PubMed ID: 21073995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The malaria vaccine--status quo 2013.
    Heppner DG
    Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against malaria.
    Ouattara A; Laurens MB
    Clin Infect Dis; 2015 Mar; 60(6):930-6. PubMed ID: 25452593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RTS,S malaria vaccine.
    Casares S; Brumeanu TD; Richie TL
    Vaccine; 2010 Jul; 28(31):4880-94. PubMed ID: 20553771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of the RTS,S malaria vaccine candidate: challenges and lessons.
    Ballou WR
    Parasite Immunol; 2009 Sep; 31(9):492-500. PubMed ID: 19691554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria.
    Wilby KJ; Lau TT; Gilchrist SE; Ensom MH
    Ann Pharmacother; 2012 Mar; 46(3):384-93. PubMed ID: 22408046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
    Nunes JK; Woods C; Carter T; Raphael T; Morin MJ; Diallo D; Leboulleux D; Jain S; Loucq C; Kaslow DC; Birkett AJ
    Vaccine; 2014 Sep; 32(43):5531-9. PubMed ID: 25077422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The path of malaria vaccine development: challenges and perspectives.
    Arama C; Troye-Blomberg M
    J Intern Med; 2014 May; 275(5):456-66. PubMed ID: 24635625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of vaccine research and development of vaccines for malaria.
    Birkett AJ
    Vaccine; 2016 Jun; 34(26):2915-2920. PubMed ID: 26993333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies & recent development of transmission-blocking vaccines against
    Chaturvedi N; Bharti PK; Tiwari A; Singh N
    Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing empiricism in malaria vaccine design.
    Moorthy VS; Kieny MP
    Lancet Infect Dis; 2010 Mar; 10(3):204-11. PubMed ID: 20185099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
    Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of vaccines for Plasmodium vivax malaria.
    Mueller I; Shakri AR; Chitnis CE
    Vaccine; 2015 Dec; 33(52):7489-95. PubMed ID: 26428453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.